|
@peterbachmd | |||||
|
Just out @NEJM from @DhruvKhullar et al. The structure of rewards (and costs) in pharmaceutical drug development. We introduce the 'reward box' interactive graphic to see how the elements interplay, how specific policies affect it. nejm.org/doi/full/10.10…
|
||||||
|
||||||
|
|
Peter B. Bach, MD
@peterbachmd
|
29. sij |
|
Here's a link to the interactive graphic: nejm.org/doi/full/10.10…
|
||
|
||
|
|
Peter B. Bach, MD
@peterbachmd
|
29. sij |
|
And here is a sample of 3 policies we describe and how they alter the Reward Box shape and thus the risk and reward of developing particular types of drugs: pic.twitter.com/lJd213pOVo
|
||
|
|
||
|
|
Peter B. Bach, MD
@peterbachmd
|
29. sij |
|
Graphic labeled the 'Reward Box' to enable the double entendre sub-header in the title. But also, we want policymakers to in fact 'think inside the box'. The market is a policy construct, it is not 'free'. The industry sees it all of a piece, policy makers should too.
|
||
|
|
||
|
Santosh Shevade
@santoshshevade
|
30. sij |
|
#innovation period also needs to opened up further to understand flow of innovation, which has changed drastically in the last few years.. #biopharma #pharma #healthcare
|
||
|
|
||